Tonix Pharmaceuticals sues Dr. Reddy's over TONMYA patent infringement
TNXP•Tonix Pharmaceuticals sued Dr. Reddy's Laboratories on November 13, 2026, over its generic TONMYA application, triggering a stay of final FDA approval for up to 30 months, subject to exceptions.
1. Patent lawsuit
Tonix Pharmaceuticals sued Dr. Reddy's Laboratories in New Jersey federal court on November 13, 2026. The case follows an October 1 notice that Dr. Reddy's had applied to market generic TONMYA 2.8 mg sublingual tablets and challenged four listed patents. Tonix seeks to block FDA approval until the last asserted patent expires.
